| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.066 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.019 | 0.8 |